Effect of Secukinumab on Radiographic Progression in Ankylosing Spondylitis as Compared to GP2017 (Adalimumab Biosimilar)
Clinical trial NCT03259074 · COMPLETED
Trial details
- NCT number
- NCT03259074
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-30
- Primary completion
- 2021-11-12
- Enrollment
- 859
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.